Long-term survival of patients with small intestinal carcinoid tumors.
Midgut carcinoid tumors are rare and have a markedly better prognosis than adenocarcinoma in the small intestine. New diagnostic methods and medical as well as surgical therapies have evolved during the last decades, leading to more active care of these patients. Patients with small intestinal carcinoids diagnosed from 1960 to 2000 in the duodenum (n = 89) and jejunum/ileum (n = 2437) were identified in the Swedish Cancer Registry. Cases without histologic verification and autopsy cases were excluded. Overall, cause-specific and relative survival were calculated. The overall 5-, 10-, and 15 year survivals were, respectively, 60%, 46%, and 28% for duodenal tumors and 56%, 36%, and 23% for jejunal/ileal tumors. Cause-specific 5-, 10-, and 15-year survival was 94% for all three follow-up periods for duodenal tumors and 87%, 80%, and 77% for those in the jejunum/ileum. The corresponding relative survivals were, respectively, 72%, 67%, and 51% for duodenal tumors and 67%, 54%, and 44% for those in the jejunum/ileum. Sex did not influence overall or cause-specific survival. The age at diagnosis correlated inversely with overall and cause-specific survival for tumors in the jejunum/ileum. For tumors in the jejunum/ileum, the overall and cause-specific survival correlated with the time period of diagnosis, with a more favorable prognosis for those diagnosed in recent years. A multivariate Cox proportional hazards model showed similar results. We concluded that young age and diagnosis in recent years are positive predictors of survival for patients with midgut carcinoids. The divergence between cause-specific and relative survival implies the need for a more detailed analysis of the causes of death of these patients.
Zar
Niklas
N
Department of Surgery, Ryhov County Hospital, SE-551 85 Jönköping, Sweden.
Garmo
Hans
H
Holmberg
Lars
L
Rastad
Jonas
J
Hellman
Per
P
D000328:Adult; D000367:Age Factors; D000368:Aged; D002276:Carcinoid Tumor / Q000401:mortality*; D004379:Duodenal Neoplasms / Q000401:mortality; D005260:Female; D006801:Humans; D007078:Ileal Neoplasms / Q000401:mortality; D007414:Intestinal Neoplasms / Q000401:mortality*; D007580:Jejunal Neoplasms / Q000401:mortality; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D016019:Survival Analysis; D013548:Sweden / Q000453:epidemiology